Hepion rallies on start of mid-stage NASH study
Seeking Alpha,
Dosing is underway in an open-label Phase 2 clinical trial, AMBITION, evaluating Hepion Pharmaceuticals' (NASDAQ: HEPA ) lead…
Dosing is underway in an open-label Phase 2 clinical trial, AMBITION, evaluating Hepion Pharmaceuticals' (NASDAQ: HEPA ) lead…
Nano cap Hepion Pharmaceuticals (NASDAQ: HEPA ) announces encouraging results from a Japan-based lab study evaluating lead…
Thinly traded nano cap Hepion Pharmaceuticals (NASDAQ: HEPA ) is up 80% premarket on increased volume in reaction to…
Thinly traded nano cap ContraVir Pharmaceuticals (NASDAQ:CTRV) is up 139% premarket on increased volume in reaction to positive…